2,7–Dichloro-alpha-(dibutylamino)methyl-9H-fluorene-4-methanol (DBA)

2,7–Dichloro-alpha-(dibutylamino)methyl-9H-fluorene-4-methanol (DBA) is a high-value pharmaceutical intermediate widely used in the synthesis of antimalarial active pharmaceutical ingredients such as Lumefantrine. It serves as a key building block in the development of fluorene-based compounds utilized in modern pharmaceutical formulations.

This intermediate is commonly applied in multi-step organic synthesis processes where high purity, stability, and consistency are essential. It plays a crucial role in the production of Lumefantrine, supporting effective antimalarial drug manufacturing. Due to its reliable performance and controlled reactivity, it is suitable for both laboratory research and large-scale industrial pharmaceutical applications.

As a trusted global supplier and exporter from India, we ensure high-quality DBA with consistent purity and performance. Our product is manufactured under stringent quality control standards and supplied to meet international requirements for pharmaceutical manufacturing and global export markets.

Applications:

• Intermediate for Lumefantrine synthesis
• Antimalarial API manufacturing
• Pharmaceutical intermediate development
• Fluorene-based compound synthesis
• Organic and medicinal chemistry research
• Large-scale pharmaceutical production

Key Features:

• High purity and consistent quality
• Excellent stability and process reliability
• Suitable for pharmaceutical-grade applications
• Efficient performance in multi-step synthesis
• Ideal for industrial and research use

Export & Quality Assurance:

Manufactured under strict quality control systems, this product is available with COA, MSDS, and TDS documentation. We ensure secure packaging, consistent batch quality, and compliance with international standards, making it suitable for global pharmaceutical markets.